Evidence brief · Supplement
Gynostemma (Jiaogulan) for Metabolic markers
Evidence grade C — Small trials
- Overall grade
- Grade C
- Last revised
- 1
- graded outcome
- 0
- references listed
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
1 at grade C — 1 graded row
What is known
Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.
- Metabolic markersEvidence grade C
Small trials
Smallmixed
What is uncertain
Read off the same rows as above. Nothing here is added that the entry does not itself record.
- Thin evidence: Metabolic markers (grade C).
The evidence in words
The verdict
For metabolic markers, Gynostemma (Jiaogulan) earns evidence grade C (small effect, mixed consistency) — the evidence is limited or mixed. Small trials
How it might work
Gypenosides activate AMPK (like berberine) and have adaptogenic, antioxidant activity.
How to use it
Safety & cautions
Generally safe; possible additive glucose lowering.
Bottom line
An AMPK-activating adaptogen with early metabolic promise. Low-risk; evidence still thin.
Goes with
- Gynostemma (Jiaogulan)Read the full Gynostemma (Jiaogulan) monographEvidence grade C
Related reading
Entries that share this one's tags or conditions.
- Berberine for Fasting glucose / HbA1cEvidence grade B — Meaningful reductionsEvidence grade B
- Berberine for LDL / triglyceridesEvidence grade B — Modest loweringEvidence grade B
- Berberine for Type 2 diabetes / prediabetesEvidence grade B — Adjunct, with careEvidence grade B
- Cinnamon for Fasting glucoseEvidence grade C — InconsistentEvidence grade C
Sources
This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.
Last revised . A grade is this entry's reading of the evidence, not medical advice.